DKK1 as a serum biomarker for hepatocellular carcinoma.
作者信息
Prieto Peter A, Cha Charles H
机构信息
Department of Surgery, Yale University School of Medicine, New Haven CT, USA;
Department of Surgery, Yale University School of Medicine, New Haven CT, USA; ; Section of Surgical Oncology, Yale University School of Medicine, New Haven CT 06520 USA.
出版信息
Hepatobiliary Surg Nutr. 2013 Jun;2(3):127-8. doi: 10.3978/j.issn.2304-3881.2012.10.12.
Abstract
摘要
相似文献
1
DKK1 as a serum biomarker for hepatocellular carcinoma.DKK1作为肝细胞癌的血清生物标志物
Hepatobiliary Surg Nutr. 2013 Jun;2(3):127-8. doi: 10.3978/j.issn.2304-3881.2012.10.12.
2
Significance of serum DKK1 as a diagnostic biomarker in hepatocellular carcinoma.血清 DKK1 作为肝细胞癌诊断标志物的意义。
Future Oncol. 2012 Dec;8(12):1525-8. doi: 10.2217/fon.12.147.
3
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.血清 DKK1 作为肝细胞癌的蛋白质生物标志物：一项大规模、多中心研究。
Lancet Oncol. 2012 Aug;13(8):817-26. doi: 10.1016/S1470-2045(12)70233-4. Epub 2012 Jun 26.
4
Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.骨桥蛋白和Dickkopf相关蛋白1对肝癌肝切除术后患者的长期预后影响
Pathol Res Pract. 2018 Jun;214(6):814-820. doi: 10.1016/j.prp.2018.05.002. Epub 2018 May 6.
5
TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.甲胎蛋白异质体（TEMs）而非DKK1可作为甲胎蛋白（AFP）的补充生物标志物，用于诊断AFP阴性的肝细胞癌。
PLoS One. 2017 Sep 13;12(9):e0183880. doi: 10.1371/journal.pone.0183880. eCollection 2017.
6
Dickkopf-1 (DKK1) promotes invasion and metastasis of hepatocellular carcinoma.Dickkopf-1（DKK1）促进肝癌的侵袭和转移。
Dig Liver Dis. 2013 Mar;45(3):251-7. doi: 10.1016/j.dld.2012.10.020. Epub 2012 Dec 20.
7
Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma.血清和组织 Dickkopf-1 水平在人肝细胞癌中的临床病理和预后意义。
Liver Int. 2011 Nov;31(10):1494-504. doi: 10.1111/j.1478-3231.2011.02597.x. Epub 2011 Aug 4.
8
Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.与单独使用任何一种标志物相比，DKK1和甲胎蛋白（AFP）联合使用可提高肝细胞癌的诊断准确性。
Turk J Gastroenterol. 2016 Jul;27(4):375-81. doi: 10.5152/tjg.2016.15523.
9
Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma.Dickkopf-1和双调蛋白作为肝细胞癌的新型生物标志物和潜在治疗靶点
Int J Hematol Oncol Stem Cell Res. 2019 Jul 1;13(3):153-163.
10
Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.血清Dickkopf-1是一种用于胰腺癌诊断和预后的新型血清学生物标志物。
Oncotarget. 2015 Aug 14;6(23):19907-17. doi: 10.18632/oncotarget.4529.
引用本文的文献
1
Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy.血清Dickkopf-1作为肝细胞癌诊断及消融治疗后随访的新型生物标志物
Cancer Manag Res. 2019 Dec 17;11:10555-10562. doi: 10.2147/CMAR.S218532. eCollection 2019.
2
Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.简化的HCC-ART评分，用于在广泛使用的奥田、CLIP和BCLC分期系统中对小尺寸和早期肝细胞癌进行高灵敏度检测。
Int J Clin Oncol. 2017 Apr;22(2):332-339. doi: 10.1007/s10147-016-1066-x. Epub 2016 Nov 18.
3
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma.Eag1通道作为肝细胞癌潜在的早期生物标志物。
Biologics. 2016 Sep 20;10:139-148. doi: 10.2147/BTT.S87402. eCollection 2016.
4
Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.整合微阵列数据以揭示肝细胞癌发病机制中的调控模式
Gut Liver. 2017 Jan 15;11(1):112-120. doi: 10.5009/gnl16063.
5
Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma.生物标志物在肝细胞癌预测和诊断中的作用。
World J Hepatol. 2015 Oct 18;7(23):2474-81. doi: 10.4254/wjh.v7.i23.2474.
6
A phylogenetic analysis of the ubiquitin superfamily based on sequence and structural information.
Mol Biol Rep. 2014 Sep;41(9):6083-8. doi: 10.1007/s11033-014-3486-x. Epub 2014 Jul 6.
7
Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions.甲胎蛋白阴性小肝病变的临床诊断与治疗。
Chin J Cancer Res. 2013 Aug;25(4):382-8. doi: 10.3978/j.issn.1000-9604.2013.08.12.
本文引用的文献
1
MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?微小 RNA：在肝细胞癌的诊断、预后和治疗中有何新工具？
Hepatology. 2013 Feb;57(2):840-7. doi: 10.1002/hep.26095. Epub 2012 Dec 26.
2
Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.骨桥蛋白启动子多态性在 -443 位点显著影响人肝细胞癌的转移和预后。
Hepatology. 2013 Mar;57(3):1024-34. doi: 10.1002/hep.26103. Epub 2013 Feb 11.
3
Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.可溶性 MICA 及其变异体可作为 HBV 诱导的肝细胞癌的预后生物标志物。
PLoS One. 2012;7(9):e44743. doi: 10.1371/journal.pone.0044743. Epub 2012 Sep 14.
4
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.血清 DKK1 作为肝细胞癌的蛋白质生物标志物：一项大规模、多中心研究。
Lancet Oncol. 2012 Aug;13(8):817-26. doi: 10.1016/S1470-2045(12)70233-4. Epub 2012 Jun 26.
5
Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations.肝细胞癌筛查：美国肝病研究协会建议的基本原理
Hepatology. 2012 Sep;56(3):793-6. doi: 10.1002/hep.25869. Epub 2012 Jul 30.
6
Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival.中介素在肝细胞癌中过表达，并调节细胞增殖和存活。
Cancer Sci. 2012 Aug;103(8):1474-80. doi: 10.1111/j.1349-7006.2012.02341.x. Epub 2012 Jul 11.
7
A novel screening biomarker in gastric cancer: serum Dickkopf-1.胃癌中的一种新型筛查生物标志物：血清Dickkopf-1。
Hepatogastroenterology. 2012 Jul-Aug;59(117):1661-4. doi: 10.5754/hge11516.
8
Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.中国的乙型肝炎和丙型肝炎病毒感染与肝细胞癌：流行病学和控制措施综述。
J Epidemiol. 2011;21(6):401-16. doi: 10.2188/jea.je20100190. Epub 2011 Oct 22.
9
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.全球范围内乙型肝炎病毒和丙型肝炎病毒感染对肝硬化和原发性肝癌的影响。
J Hepatol. 2006 Oct;45(4):529-38. doi: 10.1016/j.jhep.2006.05.013. Epub 2006 Jun 23.
10
Screening tests for hepatocellular carcinoma.肝细胞癌的筛查试验
Clin Liver Dis. 2005 May;9(2):235-51, vi. doi: 10.1016/j.cld.2004.12.006.
Zotero 插件